QM · rank #5 · 2026-09-07
JEN
XETRA · EUR · $2.64B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +107.80% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +8.8% |
| Profit margin Net profit margin, trailing 12 months. | +8.3% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $2.64B |
| Anchor (recent) Close on 2026-08-07 | $39.12 |
| Anchor (far) Close on 2025-08-08 | $18.83 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Jenoptik is a German photonics group supplying high-precision optical components, metrology, and photonic modules to OEM customers in semiconductor equipment, medical technology, and smart mobility markets.
Rationale
The momentum_12_1 signal of 1.08 is directly supported by a guidance raise to 5–9% revenue growth and 20–21% EBITDA margin after H1 2026 beat, while ROE of 8.9% and 8.3% profit margins reflect genuine quality improvement from expanding EBITDA margins and net income nearly doubling year-on-year, not financial engineering.
Material risks
- 1Semiconductor equipment OEM concentration means the book-to-bill of 1.4x and margin expansion are heavily cycle-dependent — a capex pause by major fab customers (ASML, Applied Materials ecosystem) could rapidly deflate both the order backlog of €825m and the quality metrics underpinning the screen.
- 2H1 2026 reported revenue growth of only ~1% (vs. ~3% constant currency) reveals meaningful FX drag, and with only modest top-line expansion despite record order intake, any further euro strengthening or order-to-revenue conversion delays could stall the momentum signal before the guided H2 acceleration materializes.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.